Live News Categoriesequity

Akeso, Inc. (AKESF) News

Track canonical SquawkNews coverage tagged to AKESF, Akeso, Inc.. This hub brings together deduplicated headlines about otc markets otcpk, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol AKESF Asset equity Sector Markets 90 days 1 Last 11.8 Updated Sep 13, 2026, 05:23 PM UTC Open live news feed

L Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial Summit Therapeutics NASDAQ:SMMT on Sunday said ivonescimab significantly extended survival compared with Merck’s NYSE:MRK Keytruda in a late-stage lung cancer trial conducted by its partner Akeso OTC:AKESF in China.Ivone GEOPOLITICS | Sep 13, 2026, 05:23 PM UTC